Morikawa S

No ORCID on file · 1 paper in corpus · active 2022
2022
Adverse reactions to mRNA coronavirus disease 2019 (COVID-19) vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 576 medical staff.
Fujita medical journal ·doi:10.20407/fmj.2021-009

ObjectivesVarious measures have been taken to curb the COVID-19 epidemic, but their effect has been limited. Vaccines are expected to make a definite improvement. In Japan, vaccination began in February 2021. However, there are very few rep…